Timo Muhonen - Concepedia

Author

Timo Muhonen

Also Known As

Muhonen, T., Muhonen, Timo, T Muhonen, T. MUHONEN, T. Muhonen, T.T. Muhonen, TIMO MUHONEN, Timo Muhonen, Timo T. Muhonen

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Helsinki University Hospital University of Helsinki Turku University Hospital Kuopio University Hospital Tampere University Hospital

About

Timo Muhonen is an author at Helsinki University Hospital specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	14	414
2	Health Sciences	3	3	73
3	Cell Biology	2	2	23
4	Public Health	1	1	15
5	Epidemiology	1	1	15

Timo Muhonen

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Patients With Severe Depression May Benefit From Buspirone Augmentation of Selective Serotonin Reuptake Inhibitors Björn Appelberg, Erkka Syvälahti, T. Koskinen, The Journal of Clinical Psychiatry	2001	154
A promising interferon plus four-drug chemotherapy regimen for metastatic melanoma. Seppo Pyrhönen, Marjo Hahka‐Kemppinen, Timo Muhonen Journal of Clinical Oncology	1992	110
Repeated centralized multidisciplinary team assessment of resectability, clinical behavior, and outcomes in 1086 Finnish metastatic colorectal cancer patients (RAXO): A nationwide prospective intervention study Pia Österlund, Tapio K. Salminen, Leena-Maija Soveri, The Lancet Regional Health - Europe	2021	104
5-HT3 receptor antagonists in the prophylaxis of acute vomiting induced by moderately emetogenic chemotherapy—A randomised study Ismo T. Jantunen, Timo Muhonen, Vesa Kataja, European Journal of Cancer Gastrointestinal PharmacologyMedicineClinical PharmacologyPharmacotherapyEmetogenic Chemotherapy—a	1993	101
A low proportion of BRCA2 mutations in Finnish breast cancer families. Paula Vehmanen, Lori S. Friedman, Hannaleena Eerola, PubMed	1997	91
Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD), and human leukocyte interferon for metastatic uveal melanoma Seppo Pyrhönen, Marjo Hahka‐Kemppinen, Timo Muhonen, Cancer	2002	78
Prognostic value of tumour vascularity in metastatic melanoma and association of blood vessel density with vascular endothelial growth factor expression Tatyana Vlaykova, P Laurila, Timo Muhonen, Melanoma Research	1999	71
Second cancer among long-term survivors from Hodgkin’s disease Paul Nyandoto, Timo Muhonen, Heikki Joensuu International Journal of Radiation OncologyBiologyPhysics Cancer EpidemiologyMedicineCancer ManagementSecond CancerOncology	1998	48
Alport's syndrome in 78 patients: epidemiological and clinical study Heli Pajari, H Kääriäinen, Timo Muhonen, Acta Paediatrica	1996	47
Prognostic value of tumour vascularity in primary melanoma S. llmonen, A L Kariniemi, Tatyana Vlaykova, Melanoma Research	1999	39

Page 1